GHRP-2 20mg/vial 1 Vial by Bluepeps

Usage

1. Gather supplies: Bluepeps GHRP-2 vial, bacteriostatic water, two insulin syringes (one for reconstitution, one for injection), alcohol swabs, and a sharps container.
2. Swab the vial septum with an alcohol wipe and allow it to air-dry for 10 seconds before inserting the needle.
3. Draw the calculated volume of bacteriostatic water into the first syringe and inject it slowly down the inner wall of the GHRP-2 vial — never directly onto the lyophilised cake — to prevent peptide degradation from foaming.
4. Gently rotate the vial between your palms until fully dissolved; the solution should be clear and colourless. Do not shake vigorously.
5. Using a fresh insulin syringe, draw your target dose (e.g., 30 µL = 300 mcg at 10 mg/mL concentration), tap to remove air bubbles, and administer subcutaneously into a pinched abdominal skin fold at a 45–90 degree angle.
6. After injection, cap and store the reconstituted vial at 2–8 °C; log the reconstitution date and discard the vial 28 days later regardless of remaining volume.

Warnings

Frequently asked questions

What diluent should I use to reconstitute a GHRP-2 vial?

Bacteriostatic water (BW) containing 0.9 % benzyl alcohol is the recommended diluent for GHRP-2 because it inhibits microbial growth and extends the usable life of the reconstituted solution to approximately 28 days when refrigerated. Sterile water for injection is an acceptable alternative if the entire vial will be used within 24–48 hours, but BW is strongly preferred for multi-dose vials.

How do I calculate the correct dose when reconstituting a 20 mg GHRP-2 vial?

Adding 2 mL of bacteriostatic water to the 20 mg vial produces a 10 mg/mL concentration. Each 100 µL mark on a standard insulin syringe then equals 1 mg of GHRP-2. For a 300 mcg dose, draw 30 µL. This high-concentration format reduces injection volume compared to 5 mg or 10 mg vials, which is particularly practical for subcutaneous administration.

At what temperature should a reconstituted GHRP-2 vial be stored, and for how long?

Reconstituted GHRP-2 must be stored at 2–8 °C in a dedicated refrigerator compartment away from the door (where temperature fluctuates). Under these conditions, stability is maintained for up to 28 days. Freeze-thaw cycling is damaging — never re-freeze a reconstituted vial. Discard the solution if it appears cloudy or contains visible particulates.

How do I perform a subcutaneous injection of GHRP-2 correctly?

Pinch a fold of abdominal skin 2–5 cm lateral to the navel, insert a 29–31 gauge insulin syringe at a 45–90 degree angle, aspirate briefly to confirm no vascular entry, then inject slowly. Release the skin fold before withdrawing the needle. Rotate sites systematically — for example, using a clock-face grid across both sides of the abdomen — to prevent lipohypertrophy with repeated dosing.

Why does Bluepeps offer GHRP-2 at 20 mg per vial rather than a lower concentration?

The 20 mg per vial format reduces the number of vials required over a full 8–12 week protocol, lowering reconstitution frequency and cumulative handling risk. Higher concentration stock solutions also allow smaller injection volumes per dose, which improves subcutaneous comfort and reduces local tissue stress. Bluepeps confirms potency at this specification through reversed-phase HPLC batch testing before release. (2) angle_used

Manufacturer

Distribution reliability is a cornerstone of the Bluepeps supply model: every GHRP-2 lot is dispatched with intact cold-chain packaging validated to maintain 2–8 °C conditions during transit, supported by a lot-specific certificate of analysis generated before goods leave the facility. Quality gates built into the release workflow include reversed-phase HPLC for active-content verification against the declared 20 mg specification and a Limulus Amebocyte Lysate (LAL) endotoxin assay to confirm residual biological load sits within defined safety limits. Vials are sealed under inert atmosphere following lyophilisation to prevent moisture re-absorption during distribution, ensuring the product received by the end user reflects the same analytical profile documented at manufacture.